Vident Investment Advisory’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,645
Closed -$359K 826
2023
Q2
$359K Buy
1,645
+463
+39% +$103K 0.01% 805
2023
Q1
$259K Buy
1,182
+142
+14% +$30.8K 0.01% 1007
2022
Q4
$216K Buy
+1,040
New +$228K 0.01% 1009
2022
Q2
Sell
-3,257
Closed -$788K 1358
2022
Q1
$788K Sell
3,257
-223
-6% -$53.9K 0.02% 790
2021
Q4
$906K Sell
3,480
-1,711
-33% -$444K 0.02% 742
2021
Q3
$1.37M Buy
5,191
+1,104
+27% +$302K 0.04% 581
2021
Q2
$1.01M Sell
4,087
-1,200
-23% -$252K 0.03% 649
2021
Q1
$1.02M Buy
5,287
+515
+11% +$103K 0.03% 605
2020
Q4
$1.01M Buy
4,772
+1,002
+27% +$200K 0.04% 536
2020
Q3
$647K Sell
3,770
-1,156
-23% -$213K 0.03% 609
2020
Q2
$946K Buy
4,926
+976
+25% +$160K 0.05% 495
2020
Q1
$581K Sell
3,950
-659
-14% -$105K 0.04% 540
2019
Q4
$714K Buy
4,609
+721
+19% +$104K 0.04% 461
2019
Q3
$525K Sell
3,888
-32
-0.8% -$4.19K 0.05% 323
2019
Q2
$478K Sell
3,920
-449
-10% -$49.7K 0.04% 342
2019
Q1
$454K Buy
4,369
+568
+15% +$58.6K 0.02% 594
2018
Q4
$433K Buy
+3,801
New +$407K 0.02% 628
2015
Q4
Sell
-15,282
Closed -$779K 748
2015
Q3
$779K Buy
15,282
+5,636
+58% +$303K 0.11% 277
2015
Q2
$544K Buy
9,646
+354
+4% +$22.3K 0.07% 447
2015
Q1
$667K Sell
9,292
-209
-2% -$13.6K 0.13% 224
2014
Q4
$533K Buy
+9,501
New +$496K 0.18% 220

Other funds holding RMD

Vident Investment Advisory's RMD Position: Q3 2023 in Review

Vident Investment Advisory sold out of ResMed (RMD) in Q3 2023, closing a stake of 1,645 shares — an estimated $359K sold.

Vident Investment Advisory first reported a position in RMD in Q4 2014 and held it in 21 quarters. The position peaked at $1.37M in Q3 2021. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Vident Investment Advisory reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 1,645 ResMed shares in Q3 2023, an estimated $359K.
  • Vident Investment Advisory first reported a position in ResMed in Q4 2014 and held it in 21 quarters.
  • Vident Investment Advisory's ResMed position peaked at $1.37M in Q3 2021.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.